Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Summary

This is a Phase I/Ib, randomised, double-blind, placebo-controlled study of INI-2004, administered as single or multiple doses. This study will be conducted in two parts: Phase I single ascending dose (SAD) and Phase Ib multiple ascending dose (MAD).

Timeline

Start

2023-07-04

Primary completion

2024-09-05

Completion

2024-09-05

Drugs

Indications